Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00756509
Show Display Options
Rank Status Study
1 Active, not recruiting Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Nilotinib

Study has passed its completion date and status has not been verified in more than two years.